Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection
Authors:
Open Access
- 7 July 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 23 (9) , 1123-1132
Abstract
The objective of this article is to evaluate the utility of preoperative needle biopsy (PNB) grading of hepatocellular carcinoma (HCC) as a biomarker for liver transplantation (LT) candidate selection. Given the prognostic significance of HCC tumor grade, PNB grading has been proposed as a biomarker for LT candidate selection. Clinicopathologic characteristics of HCC LT recipients (1989‐2014) with a PNB were analyzed, and the concordance of PNB grade to explant grade and vascular invasion was assessed to determine whether incorporation of PNB grade to accepted transplant criteria improved candidate selection. Of 965 patients undergoing LT for HCC, 234 (24%) underwent PNB at a median of 280 days prior to transplant. Grade by PNB had poor concordance to final explant pathology (κ = 0.22; P = 0.003), and low sensitivity (29%) and positive predictive value (35%) in identifying poorly differentiated tumors. Vascular invasion was predicted by explant pathologic grade (rs = 0.24; P < 0.001) but not PNB grade (rs = −0.05; P = 0.50). Increasing explant pathology grade (P = 0.02), but not PNB grade (P = 0.65), discriminated post‐LT HCC recurrence risk. The incorporation of PNB grade to the established radiologic Milan criteria (MC) did not result in improved prognostication of post‐LT recurrence (net reclassification index [NRI] = 0%), whereas grade by explant pathology resulted in significantly improved reclassification of risk (NRI = 19%). Preoperative determination of HCC grade by PNB has low concordance with explant pathologic grade and low sensitivity and positive predictive value in identifying poorly differentiated tumors. PNB grade did not accurately discriminate post‐LT HCC recurrence and had no utility in improving prognostication compared with the MC alone. Incorporation of PNB to guide transplant candidate selection appears unjustified. Liver Transplantation 23 1123–1132 2017 AASLD.Keywords
This publication has 40 references indexed in Scilit:
- MELD Exceptions and Rates of Waiting List OutcomesAmerican Journal of Transplantation, 2011
- Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation SystemAmerican Journal of Transplantation, 2010
- Hepatocellular carcinoma developed on compensated cirrhosis: Resection as a selection tool for liver transplantationLiver Transplantation, 2008
- Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Allocation System and Predictors of SurvivalGastroenterology, 2008
- Human skin fibroblasts: From mesodermal to hepatocyte-like differentiationHepatology, 2007
- Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be ExpandedAnnals of Surgery, 2007
- Preoperative Assessment of Hepatocellular Carcinoma Tumor Grade Using Needle BiopsyAnnals of Surgery, 2007
- The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des‐gamma‐carboxy prothrombinJournal of Surgical Oncology, 2007
- Predictors of Microvascular Invasion in Patients with Hepatocellular Carcinoma Who Are Candidates for Orthotopic Liver TransplantationJournal of Gastrointestinal Surgery, 2002
- Tumor heterogeneity in small hepatocellular carcinoma: Analysis of tumor cell proliferation, expression and mutation of p53 AND ?-cateninInternational Journal of Cancer, 2001